MS
APLT

Maven Securities’s Applied Therapeutics APLT Stock Holding History

Maven Securities’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,000
Closed -$168K – 385
2023
Q4 		$168K Buy
+50,000
New +$124K ﹤0.01% 898
2022
Q4 		– Sell
-50,000
Closed -$47K – 839
2022
Q3 		$47K Hold
50,000
– – ﹤0.01% 1073
2022
Q2 		$47K Buy
+50,000
New +$81.9K ﹤0.01% 863
2021
Q2 		– Sell
-50,000
Closed -$950K – 1048
2021
Q1 		$950K Buy
+50,000
New +$1.08M 0.04% 442

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Maven Securities's APLT Position: Q1 2024 in Review

Maven Securities sold out of Applied Therapeutics (APLT) in Q1 2024, closing a stake of 50,000 shares — an estimated $168K sold.

Maven Securities first reported a position in APLT in Q1 2021 and held it in 4 quarters. The position peaked at $950K in Q1 2021. 89 funds tracked by Wall St. Rank hold APLT as of Q1 2024.

  • Maven Securities reported no remaining Applied Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Maven Securities sold 50,000 Applied Therapeutics shares in Q1 2024, an estimated $168K.
  • Maven Securities first reported a position in Applied Therapeutics in Q1 2021 and held it in 4 quarters.
  • Maven Securities's Applied Therapeutics position peaked at $950K in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2024.

Based on Maven Securities's 13F filing for Q1 2024, filed 14 May 2024.